Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 27,497 shares at $251.95 ($6.9M) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $6.9M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $247.46 | 400 | $99K | 1.4% |
| 2 | $248.93 | 1,681 | $418K | 6.1% |
| 3 | $248.93 | 1,681 | $418K | 6.1% |
| 4 | $249.97 | 6,478 | $1.6M | 23.5% |
| 5 | $249.97 | 6,478 | $1.6M | 23.5% |
| 6 | $250.71 | 3,157 |
| $791K |
| 11.5% |
| 7 | $250.71 | 3,157 | $791K | 11.5% |
| 8 | $251.95 | 2,181 | $550K | 8.0% |
| 9 | $251.95 | 2,181 | $550K | 8.0% |
| 10 | $252.59 | 103 | $26K | 0.4% |
| Total | $250.30 avg | 27,497 | $6.9M | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |